IDEXX beats market estimates on Q4 earnings, revenue

IDEXX Laboratories Inc. (Nasdaq: IDXX), on Tuesday posted fourth-quarter earnings and revenues that exceeded market expectations and gave a bullish outlook for 2021.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing posted $2.01 in fourth-quarter earnings per diluted share, an increase of 93% over a year ago.

EPS was also well above the $1.43 consensus forecast of analysts polled by Zacks Investment Research, marking the fourth straight quarter the company has beaten market expectations. Read more

Related Posts

Maine’s first mobile biolab starts tour of rural schools in Fort Kent

FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...

12 March 2024

UMaine Augusta’s $1.75M medical lab training facility doubles student capacity

Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...

21 February 2024

UNE receives grant to research state-threatened animal

The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...

12 February 2024